1-4 of 4
Laura Fernandes
Close
Sort by
Journal Articles

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Dianne Pulte, Kelly J. Norsworthy, Laura Fernandes, Bindu Kanapuru, Catherine Lerro, Fatima Rizvi, Jonathon Vallejo, Kun Wang, Joseph Wynne, Anna Barcellos, Andrew J. Belli, Eric Hansen, Thomas Gwise, Paul Kluetz, Angelo De Claro, Ching-Kun Wang, Donna Rivera
Journal: Blood
Blood (2022) 140 (Supplement 1): 5100–5102.
https://doi.org/10.1182/blood-2022-169054
Published: 2022
Journal Articles

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz
Journal: Blood
Blood (2022) 140 (Supplement 1): 7156–7157.
https://doi.org/10.1182/blood-2022-166842
Published: 2022
Journal Articles

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

William J Archibald, Anna Barcellos, Jacob Ambrose, Andrew J. Belli, Laura Fernandes, Eric Hansen, Ching-Kun Wang, Paul M. Barr
Journal: Blood
Blood (2022) 140 (Supplement 1): 4142–4143.
https://doi.org/10.1182/blood-2022-170596
Published: 2022
Journal Articles

Characterization of Patient-Reported Outcomes in Multiple Myeloma Registrational Trials Submitted to the U.S. FDA

Laura Fernandes, PhD, Jiaxi Zhou, MS, Bellinda L King-Kallimanis, PhD, Thomas Gwise, PhD, Paul Kluetz, MD, Vishal Bhatnagar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-139700
Published: 2020